2nd World Companion Diagnostics & Liquid Biopsy Summit APAC
Partner Content
With increasing demand for targeted therapies and testing access, the Asia-Pacific region is becoming a rising player in the co-development and commercialization of drug-diagnostic strategies.
Uniting 100+ precision medicine leaders from biopharma, diagnostic development, regulation, and healthcare institutes, the 2nd World Companion Diagnostics & Liquid Biopsy Summit APAC returns to Singapore this November to help you innovate affordable, scalable, and timely testing solutions for patients across the region.
- Advance novel biomarker discovery and validation in solid and hematologic tumors
- Navigate regional and global biomarker-driven trials with centralized and decentralized vendor networks
- Uncover precision medicine applications in chronic, chronic and rare diseases with gene panels, digital and multiplex biomarkers
- Decode IVD regulation and commercialization across fragmented APAC regulations and shifting global LDT and IVDR compliance
View the official event program
With free* tickets available for biopharma professionals, visit the website to register and view eligibility criteria
